# Characterize and optimize adjuvants to test monkeypox vaccines

> **NIH NIH N01** · UNIVERSITY OF MONTANA · 2022 · $1,599,006

## Abstract

To identify novel classes of adjuvants, characterize and optimize them, and test them in vivo with various antigens from different pathogens.

## Key facts

- **NIH application ID:** 10610275
- **Project number:** 75N93019C00045-P00012-9999-2
- **Recipient organization:** UNIVERSITY OF MONTANA
- **Principal Investigator:** JAY EVANS
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1,599,006
- **Award type:** —
- **Project period:** 2021-09-30 → 2022-09-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10610275

## Citation

> US National Institutes of Health, RePORTER application 10610275, Characterize and optimize adjuvants to test monkeypox vaccines (75N93019C00045-P00012-9999-2). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10610275. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*